New data shows GSK-Vir drug works against all Omicron mutations




  • In US
  • 2021-12-07 07:29:11Z
  • By Reuters
 

(Reuters) - British drugmaker GSK said on Tuesday its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies.

The data, yet to be published in a peer-reviewed medical journal, shows that the companies' treatment, sotrovimab, is effective against all 37 identified mutations to date in the spike protein, GSK said in a statement.

Last week, another pre-clinical data showed that the drug had worked against key mutations of the Omicron variant. Sotrovimab is designed to latch on to the spike protein on the surface of the coronavirus, but Omicron has been found to have an unusually high number of mutations on that protein.

"These pre-clinical data demonstrate the potential for our monoclonal antibody to be effective against the latest variant, Omicron, plus all other variants of concern defined to date by the WHO," GSK Chief Scientific Officer Hal Barron said.

GSK and Vir have been engineering so-called pseudoviruses that feature major coronavirus mutations across all suspicious variants that have emerged so far, and have run lab tests on their vulnerability to sotrovimab treatment.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Sherry Jacob-Phillips)

COMMENTS

More Related News

DeSantis fumes over FDA interference on monoclonal antibody treatments
DeSantis fumes over FDA interference on monoclonal antibody treatments

Gov. Ron DeSantis is blasting the Biden administration after the FDA revoked the use of two different monoclonal antibody treatments, forcing Florida to...

Omicron
Omicron's new variant cousin, BA.2, has arrived in the US. But don't panic yet, experts say.

Cases of omicron BA.2 have been reported in at least four states - California, New Mexico, Texas and Washington - and on three other continents.

We
We've turned the corner on omicron and GOP primary for governor could get nasty

Welcome to the Milwaukee Journal Sentinel's daily news briefing

CDC study finds shorter hospital stays during omicron wave, even as infections and death toll mount
CDC study finds shorter hospital stays during omicron wave, even as infections and death toll mount

Federal health officials reported Tuesday that the omicron variant caused less severe illness in hospitalized patients than earlier virus lineages, even...

DeSantis blasts FDA for halting drugs ineffective on omicron
DeSantis blasts FDA for halting drugs ineffective on omicron

Florida Gov. Ron DeSantis vowed Tuesday to fight a decision from federal health regulators to block two coronavirus antibody treatments after the drugs were ...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US